Search

With the increase of greenhouse gas emissions, global warming has become an urgent problem, and the use of solid adsorbents to capture CO2 gas in flue gas has attracted more and more attention. In this study, the process of CO2 capture by K2CO3 particles in the bubbling fluidized bed (BFB) is numerically simulated with Eulerian–Eulerian(E–E) two fluid model incorporating with the kinetic theory of granular flows (KTGF). The results are verified through a detailed comparison with experimental data from Ayobi et al. Furthermore, Regarding the fundamental factors influencing CO2 adsorption rate is revealed, diminishing the inlet gas superficial velocity and augmenting the particle size of the solid adsorbent both contribute to improve adsorption performance. Specifically, the adsorption rate increases from 76.7% to 81.7% at the gas superficial velocity reducing from 1.10 to 0.71 m/s, while the adsorption rate from 77.6% to 79.7% with the particle size ranging from 400 to 600 μm. Additionally, the study delves into an exploration of fluid dynamic characteristics pertaining to gas particles within the bubbling fluidized bed while systematically considering varied inlet gas superficial velocities and particle sizes. [ABSTRACT FROM AUTHOR]

Background: Curative endoscopic resection is widely used to treat colonic polyps and early stage cancers. The anesthetic strategy commonly involves the use of propofol combined with a small dose of opioids for sedation. Adverse respiratory or cardiovascular events such as hypotension often occur when attempting to achieve the necessary level of sedation. Several studies have suggested its advantages owing to the anesthetic, analgesic, and sympathomimetic properties of esketamine. However, there are no reports on curative colorectal endoscopic resection. We designed this randomized controlled trial to assess the efficacy and safety of esketamine combined with propofol for sedation in patients undergoing curative colorectal endoscopic resection. Methods: A total of 166 patients who underwent curative colorectal endoscopic resection were randomly assigned to groups A (propofol + fentanyl) or E (propofol + esketamine). Ideal sedation was assessed using the MOAA/S scale and was achieved using TCI-propofol with different doses of fentanyl and esketamine. The propofol consumption and vasoactive drug dosages were recorded. Sedation-related times, adverse events, and satisfaction were recorded. Results: Of the 160 patients, the total propofol consumption was significantly lower in group E (n = 81) (300 mg) than in group A (n = 79) (350 mg). Hypotension and bradycardia were significantly lower in Group E than in Group A. The groups showed no significant differences in other adverse events, induction time, recovery time, or patient or endoscopist satisfaction. Conclusion: Compared to fentanyl, esketamine helps decrease propofol consumption and increases cardiovascular stability during curative colorectal endoscopic resection in American Society of Anesthesiologists Class I–III patients without affecting anesthesia, patient and endoscopist satisfaction, or other adverse events. Trial registration: The study was retrospectively registered at the Chinese Clinical Trial Registry (www.chictr.org.cn; registration number: ChiCTR2300069014 on 03/03/2023). [ABSTRACT FROM AUTHOR]